Aseptic Liquid Filling: Ensuring Sterility & Safety in Pharma Manufacturing
Meet Jodie Winder: ISPE UK Affiliate Board Member &Advocate for Emerging Leaders
TriRx CEO Tim Tyson Shares Insights on BBC Radio 5`s Wake Up to Money
Survey Launched to Gain Insights into the Evolution of a Changing Pharmaceutical Market
NORWALK, Conn., July 27, 2023 /PRNewswire/ -- TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization (CDMO), welcomed the UK Government's recent announcement on England's second Investment Zone, focused on Life Sciences in the Liverpool City Region.
Shaping the Industry Landscape: Tim Tyson's Vision Shared in GBR Interview
Sodexo secures new £16.5 million 5-year contract at TriRx Pharmaceutical Services
Animal health giant Elanco completed the sale of a pair of manufacturing facilities to TriRx Pharmaceutical Services, a Connecticut-based CDMO.
TriRx was honored to welcome the That’s Nice team to Shawnee, Kansas as part of Day 29 of Pharma’s Almanac’s “Road to 50 States,” a campaign journey to discover the next big thing in pharma. While providing an overview of the Animal Health Facility, Vice President and Shawnee Site Director Mark Frohardt gives his perspective on what’s to come in the industry—including the continued growth opportunity for pet health and companion animal product lines. As the industry expands, TriRx is dedicated to fully supporting new and existing customers by creating quality products.
On Day 37 of Pharma’s Almanac’s “Road to 50 States,” a campaign journey to visit leading pharma and biotech companies across the United States, the That’s Nice team stopped in Huntsville, Alabama, where TriRx had the opportunity to showcase their Human Health Facility. In an on-site interview discussing the next big thing in pharma, Robert Perry, our Huntsville Site Director, shares his insights on the reliability of and customer confidence in the onshore supply chain as it relates to the impact of the global COVID-19 crisis.